ERBB2 and breast carcinoma: Over the years, basal-like breast cancer has become commonly known as triple-negative breast cancer (TNBC), lacking estrogen receptor (ER) and progesterone receptor (PR) expression as well as human epidermal growth factor receptor 2 (HER2) amplification; however, not all TNBCs are identified as basal-like by gene expression, and not all basal-like tumors are Triple Negative (TN) [7].